{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:38:36Z","timestamp":1792132716737,"version":"4.4.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,10,3]]},"DOI":"10.3233\/jad-160645","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T11:41:54Z","timestamp":1480419714000},"page":"809-817","source":"Crossref","is-referenced-by-count":97,"title":["Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"60","author":[{"given":"Min","family":"Kim","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejo","family":"Nevado-Holgado","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Whiley","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart G.","family":"Snowden","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilkka","family":"Soininen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kloszewska","sequence":"additional","affiliation":[{"name":"Department of Old Age Psychiatry & Psychotic Disorders, Medical University of Lodz, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mecocci","sequence":"additional","affiliation":[{"name":"Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[{"name":"Third Department of Neurology, Memory and Dementia Centre, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatrics Medicine, INSERM U 1027, Gerontopole, H\u00f4pitaux de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.B.","family":"Dobson","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Powell","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K.","family":"Lupton","sequence":"additional","affiliation":[{"name":"Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Simmons","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Velayudhan","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petroula","family":"Proitsi","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Legido-Quigley","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160645_ref1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer\u2019s disease facts and figures","volume":"11","author":"Alzheimer\u2019s, Association","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160645_ref2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-160645_ref3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"10.3233\/JAD-160645_ref4","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1021\/ac102211r","article-title":"Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography\/mass spectrometry","volume":"82","author":"Sato","year":"2010","journal-title":"Anal Chem"},{"key":"10.3233\/JAD-160645_ref5","doi-asserted-by":"crossref","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer\u2019s disease: Identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160645_ref6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-160645_ref7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuroscience.2004.08.056","article-title":"Astroglial expression of ceramide in Alzheimer\u2019s disease brains: A role during neuronal apoptosis","volume":"130","author":"Satoi","year":"2005","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-160645_ref8","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160645_ref9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease: The Women\u2019s Health and Aging Study II","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-160645_ref10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160645_ref11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","article-title":"Blood metabolite markers of preclinical Alzheimer\u2019s disease in two longitudinally followed cohorts of older individuals","volume":"12","author":"Casanova","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160645_ref12","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1038\/tp.2014.127","article-title":"Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer\u2019s disease","volume":"5","author":"Proitsi","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-160645_ref13","doi-asserted-by":"crossref","unstructured":"Proitsi P , Kim M , Whiley L , Simmons A , Sattlecker M , Velayudhan L , Lupton MK , Soininen H , Kloszewska I , Mecocci P , Tsolaki M , Vellas B , Lovestone S , Powell JF , Dobson RJ , Legido-Quigley C (2016) Association of blood lipids with Alzheimer\u2019s disease: A comprehensive lipidomics analysis. Alzheimers Dement, doi: 10.1016\/j.jalz.2016.08.003","DOI":"10.1016\/j.jalz.2016.08.003"},{"key":"10.3233\/JAD-160645_ref14","first-page":"359","article-title":"Biomarkers for disease modification trials\u2013the innovative medicines initiative and AddNeuroMed","volume":"11","author":"Lovestone","year":"2007","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-160645_ref15","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1021\/ac300716u","article-title":"In-vial dual extraction for direct LC-MS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting","volume":"84","author":"Whiley","year":"2012","journal-title":"Anal Chem"},{"key":"10.3233\/JAD-160645_ref16","doi-asserted-by":"crossref","first-page":"e24777","DOI":"10.1371\/journal.pone.0024777","article-title":"Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer\u2019s disease","volume":"6","author":"Astarita","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160645_ref17","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160645_ref18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuint.2005.11.002","article-title":"Neuropsychological and behavioural correlates of CSF biomarkers in dementia","volume":"48","author":"Engelborghs","year":"2006","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-160645_ref19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaneurol.2014.754","article-title":"Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers","volume":"71","author":"Kester","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-160645_ref20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer\u2019s and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160645_ref21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","article-title":"Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway","volume":"23","author":"Malaplate-Armand","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-160645_ref22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3233\/JAD-160645_ref23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-141899","article-title":"Metabolic modifications in human biofluids suggest the involvement of sphingolipid, antioxidant, and glutamate metabolism in Alzheimer\u2019s disease pathogenesis","volume":"46","author":"Ellis","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160645_ref24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.3233\/JAD-160645_ref25","doi-asserted-by":"crossref","first-page":"19777","DOI":"10.1074\/jbc.M300466200","article-title":"Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis","volume":"278","author":"Puglielli","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160645_ref26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.neurobiolaging.2006.06.021","article-title":"Is aging part of Alzheimer\u2019s disease, or is Alzheimer\u2019s disease part of aging?","volume":"28","author":"Swerdlow","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160645_ref27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160645_ref28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jalz.2010.03.014","article-title":"Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss","volume":"6","author":"Mielke","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160645_ref29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/0271678X15611678","article-title":"Blood metabolite markers of cognitive performance and brain function in aging","volume":"36","author":"Simpson","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-160645_ref30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2014.04.032","article-title":"Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study","volume":"235","author":"Fitzpatrick","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.3233\/JAD-160645_ref31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.3233\/JAD-160645_ref32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND diet associated with reduced incidence of Alzheimer\u2019s disease","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160645_ref33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1079\/BJN2002804","article-title":"Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer\u2019s disease: A case-control study","volume":"89","author":"Tully","year":"2003","journal-title":"Br J Nutr"},{"key":"10.3233\/JAD-160645_ref34","first-page":"207","article-title":"Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structural-functional synergies with cell membrane phospholipids","volume":"12","author":"Kidd","year":"2007","journal-title":"Altern Med Rev"},{"key":"10.3233\/JAD-160645_ref35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1474-9726.2012.00865.x","article-title":"Human serum metabolic profiles are age dependent","volume":"11","author":"Yu","year":"2012","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-160645_ref36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-94-007-0495-4_4","volume-title":"Molecular Basis of Health and Disease","author":"Das","year":"2011"},{"key":"10.3233\/JAD-160645_ref37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat Rev Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:52Z","timestamp":1777370692000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160645"}},"subtitle":[],"editor":[{"given":"Michelle","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Pilar","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":37,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160645","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}